YB
Yuanbao Inc. (NASDAQ)
Technology — Software - Application
Yuanbao Inc., together with its subsidiaries, provides insurance brokerage and agency licenses services in the People's Republic of China. The company offers medical, critical illness, accident, property, and pet insurance products. Yuanbao Inc. was incorporated in 2019 and is headquartered in Beijing, the People's Republic of China.
None
1 analysts
$13.79
$-0.22 (-1.54%)
Target:
$17.90
(29.8%)
Sign in to add YB to a watchlist or set price alerts.
Price History
52-Week Range
Fundamentals
| Market Cap | $737.28M |
| P/E Ratio (TTM) | 3.83 |
| Forward P/E | 3.25 |
| EPS (TTM) | $4.18 |
| Dividend Yield | 7.69% |
| Profit Margin | 29.67% |
| Revenue Growth | 35.60% |
| ROE | 47.88% |
| Debt/Equity | 0.11 |
| Recommendation | None |
| Analyst Target | $17.90 |
| Analysts | 1 |
| Indexes | NASDAQ |
Technical Indicators
| RSI (14) | 48.6 |
| Beta | - |
| SMA 20 | - |
| SMA 40 | - |
| 52-Week High | $31.00 |
| 52-Week Low | $12.01 |
| 50-Day Avg | $15.21 |
| 200-Day Avg | $19.08 |
| Avg Volume | 40.8K |
| Volume | 16.4K |
Performance Analysis
BULLISHYB shows predominantly bullish signals based on its fundamentals and technicals.
+
Trading near its 52-week low ($12.01), which could present a value opportunity.
~
RSI at 48.6 is in neutral territory.
-
Price is below both the 50-day and 200-day moving averages — in a downtrend.
+
P/E of 3.8 suggests the stock may be undervalued.
+
Strong revenue growth of 35.6% year-over-year.
+
Healthy profit margin of 29.7%.
~
Wall Street consensus is "none" from 1 analysts.
+
Average analyst target of $17.90 implies 29.8% upside.
Recent News
Loading news...
Last updated: Jul 02, 2026 13:38 UTC
Back to Screener Export Report